Nbc Securities, Inc. Acurx Pharmaceuticals, Inc. Transaction History
Nbc Securities, Inc.
- $1.17 Billion
- Q1 2025
A detailed history of Nbc Securities, Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 30,000 shares of ACXP stock, worth $12,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000
Previous 19
157794.74%
Holding current value
$12,900
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.52MCall Options Held
13.6KPut Options Held
4K-
Vanguard Group Inc Valley Forge, PA529KShares$227,6200.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$157,6270.08% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$62,9950.0% of portfolio
-
Morgan Stanley New York, NY106KShares$45,6660.0% of portfolio
-
Vanguard Capital Wealth Advisors67.5KShares$29,0250.03% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $4.97M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...